ストックスクリーナーアプリを入手
82.39
0.80%
0.65
アフターアワーズ：
82.00
-0.39
-0.47%
前日終値:
$81.74
開ける：
$82.1
24時間の取引高:
506.58K
Relative Volume:
0.48
時価総額：
$2.46B
収益：
$442.68M
当期純損益:
$-77.81M
株価収益率:
-30.88
EPS:
-2.6684
ネットキャッシュフロー:
$-28.65M
1週間 パフォーマンス:
+17.85%
1か月 パフォーマンス:
+25.52%
6か月 パフォーマンス:
-9.13%
1年 パフォーマンス:
-29.22%
1日の値動き範囲:
$81.46
$83.87
1週間の範囲:
$65.74
$83.87
52週間の値動き範囲:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Compare WGS vs TMO, DHR, NTRA, IDXX, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
82.39 | 2.44B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
603.01 | 223.70B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.79 | 145.83B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
315.96 | 45.08B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
570.58 | 46.22B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.24 | 42.22B | 7.23B | 1.41B | 1.09B | 4.979 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-09 | 開始されました | Piper Sandler | Overweight |
| 2025-05-15 | 開始されました | Guggenheim | Buy |
| 2025-05-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-10 | 開始されました | Craig Hallum | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
すべてを表示
Genedx Holdings Corp (WGS) 最新ニュース
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan
GeneDx at Canaccord Genuity conference: volume rises, collections lag - Investing.com
GeneDx Holdings (WGS) Is Up 14.8% After Loss-Making Q2, New Capital Raise And Guidance Reaffirmation - simplywall.st
GeneDx launches online exome testing for pediatric patients - Investing.com
GeneDx Lets Families Start Children’s Exome Testing Online - Stock Titan
Assenagon Asset Management S.A. Acquires 208,305 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - The National Law Review
GeneDx Holdings Corp. $WGS Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone - finance.yahoo.com
WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS - The National Law Review
GeneDx Holdings Corp (WGS) Stock News Today - TradingKey
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
GeneDx to Participate in Upcoming Investor Conferences - marketscreener.com
GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Eli Casdin-affiliated funds buy $11.1m in GeneDx shares By Investing.com - Investing.com Nigeria
GeneDx Holdings Corp. Earnings Call Highlights Risks - The Globe and Mail
GeneDx (WGS) Stock Climbs On Strong Margins As Reimbursement Lags - Sahm
GeneDx Holdings Corp. (WGS) Options Chain - Yahoo! Finance Canada
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings - Investing.com
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings By Investing.com - Investing.com Nigeria
GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $85.89, Implies 27% Upside - TradingView
GeneDx Holdings Corp. Q2 2026 Earnings Call Summary - finance.yahoo.com
GeneDx Holdings Corp. (WGS) Stock Analysis: Strong Buy Ratings and 20% Potential Upside - DirectorsTalk Interviews
GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ... By GuruFocus - Investing.com Canada
GeneDx Holdings (WGS) Is Up 9.7% After Beating Q2 Estimates And Reaffirming 2026 OutlookHas The Bull Case Changed? - simplywall.st
GeneDx Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook - finance.yahoo.com
GeneDx Holdings Corp. (WGS) Releases Q2 2026 Earnings: Revenue Beats Estimates but Losses Persist - Quiver Quantitative
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - Morningstar
Earnings Flash (WGS) GeneDx Holdings Corp. Reports Q2 Revenue $114.4M, vs. FactSet Est of $111.0M - marketscreener.com
GeneDx Reports Q2 2026 Revenue $114.4M, Adjusted Gross Margin ~70%, Reaffirms FY26 Guidance - TradingView
GeneDx Holdings Corp. Q2 2026: Revenue $114.4M, EPS $(0.60) — 10-Q Summary - TradingView
[10-Q] GeneDx Holdings Corp. Quarterly Earnings Report - Stock Titan
GeneDx Holdings (Nasdaq: WGS) grows Q2 2026 revenue to $114.4M amid GAAP loss - Stock Titan
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
GeneDx Holdings Corp. $WGS Stock Position Raised by Renaissance Technologies LLC - MarketBeat
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. LawsuitWGS - PR Newswire
DEADLINE TODAY: GeneDx Holdings Corp. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsWGS - Barchart.com
GeneDx Holdings Corp. 24 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp.WGS - ACCESS Newswire
WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Westerly Sun
WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. ... - Caledonian Record
GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & - GlobeNewswire
MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Investors with - GlobeNewswire
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - The Globe and Mail
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Bank of New York Mellon Corp Acquires 87,922 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
WGS DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, - GlobeNewswire
Genedx Holdings Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Genedx Holdings Corp (WGS) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.87%
大文字化:
|
ボリューム (24 時間):